查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1930065

全球注射笔针市场：市场规模、市场占有率、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测（2025-2034）

Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

注射笔针市场成长驱动因素

2025年全球注射笔针市场规模为24.1亿美元。在本报告涵盖的预测期内，预计该市场规模将在2026年增长至25.6亿美元，并在2034年达到45.8亿美元，2026年至2034年的复合年增长率（CAGR）为7.50%。北美地区在2025年占全球市场39.60%的占有率，这主要得益于注射给药装置的高渗透率以及许多成熟医疗器材製造商的强大影响力。

注射笔针头是与注射笔配合使用的一次性医疗器械，用于注射胰岛素、GLP-1受体激动剂、生长激素和其他注射疗法等药物。这些针头在单次或有限使用后需要更换，这显着增加了持续的需求。糖尿病、骨质疏鬆症、肥胖症和荷尔蒙缺乏症等慢性疾病的日益普遍是市场扩张的主要驱动因素。

市场驱动因素

全球慢性疾病的增加是注射笔针头需求的主要驱动因素。预计到2025年，糖尿病将成为注射笔针头使用量最大的疾病，这主要是由于患者长期依赖胰岛素。 GLP-1注射疗法在糖尿病和肥胖症治疗中的日益普及，进一步增加了对注射笔给药系统的依赖。

市场参与者正积极透过收购、合作和新产品发布来扩展其产品组合。例如，MTD Medical Technology and Devices S.p.A. 透过收购胰岛素笔针和血糖监测业务，并加强其在多个地区的供应链，巩固了其在胰岛素笔针领域的市场地位。此外，胰岛素笔针作为非处方药在已开发市场日益普及，也促进了其可及性和销售量的成长。

市场限制因子

儘管市场需求强劲，胰岛素笔针市场仍存在一些限制因素。针刺伤、注射部位反应和感染传播等风险仍然是患者和医护人员关注的主要问题。不正确的注射技术和在同一部位重复注射会导致脂肪增生和皮肤感染等併发症。此外，包括口服糖尿病和骨质疏鬆症药物在内的替代疗法的出现，也继续限制了胰岛素笔针在某些患者群体中的市场渗透率。

细分市场分析

依产品类型划分：

标准胰岛素笔针保持其主导地位，预计到 2026 年将占全球 67.97% 的市场占有率。其广泛应用主要得益于其成本效益和糖尿病患者的高接受度。由于人们对预防针刺伤的意识不断提高，预计安全胰岛素笔针的市场成长速度将更快。

依药物类型划分：

胰岛素细分市场预计将在 2026 年占主导地位，市占率达 75.39%，这反映了糖尿病管理对胰岛素的高度依赖。预计到 2034 年，GLP-1 及其他注射类药物市场将持续成长。

依疾病分类：

糖尿病作为主要适应症，在 2026 年占全球需求的 83.59%。这一主导地位得益于糖尿病盛行率的上升以及製造商在胰岛素输注系统方面的持续创新。

依针头尺寸分类：

由于疼痛感和肌肉注射风险较低，4 毫米针头在 2026 年占了 49.61% 的市场占有率。 6 毫米针头因其在安全性和给药效率方面的平衡性而需求不断增长。

依分销管道分类：

2025 年，零售药局将主导市场，这主要得益于其对病患便利性和非处方药供应的重视。受送货上门的便利性和数位化医疗普及的推动，预计到 2034 年，线上药局将快速成长。

区域趋势

北美凭藉其先进的医疗基础设施和强大的製造商实力，仍然是关键区域。在 Envector 和 Cardinal Health 等公司的支持下，到 2026 年，该地区市场规模达到 9.6 亿美元。

欧洲预计到 2034 年将保持稳定成长，这主要得益于糖尿病的高发生率和人们对胰岛素自我注射疗法的日益青睐。亚太地区预计将呈现最高的成长率，这得益于不断扩大的患者群体、人们对注射疗法的认识不断提高，以及中国、印度、日本和其他地区对製药业的投资增加。

主要公司趋势

竞争格局包括 Novo Nordisk A/S、Terumo Corporation、BD、Owen Mumford 和 B. Braun SE。这些公司将持续专注于创新、提升安全设计并拓展全球分销网络。

回报内容

"全球注射笔针头市场" 报告详细分析了2025年、2026年和2034年的市场规模趋势，以及细分市场分析、区域展望、竞争格局和新冠疫情的影响。本报告也涵盖了併购、合作、新产品发布等主要产业趋势，这些趋势将在预测期内影响市场动态。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家和地区糖尿病盛行率（2025 年）
  • 主要国家和地区肥胖盛行率（2025 年）
  • 主要产业趋势：併购、业务合作关係等
  • 新冠疫情对市场的影响

第五章 全球胰岛素笔针市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 标准胰岛素笔针
    • 安全胰岛素笔针
  • 市场分析、洞察与预测：依药物类型划分
    • 胰岛素
    • GLP-1
    • 生长激素
    • 其他
  • 市场分析、洞察与预测：依疾病划分
    • 糖尿病
    • 肥胖症
    • 荷尔蒙缺乏症
    • 其他
  • 市场分析、洞察与预测：依针头尺寸划分
    • 4毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市场分析、洞察与预测：依销售管道划分
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 澳大利亚
    • 印度
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 南非
    • 海湾合作委员会 (GCC) 国家
    • 其他拉丁美洲国家

第十一章：竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • 诺和诺德公司
    • Embecta 公司
    • B. Braun SE
    • Owen Mumford
    • BD
    • Cardinal Health
    • SOL-Millennium
    • Terumo Corporation
    • MTD Medical Technology and Devices S.p.A.
    • UltiMed, Inc.
    • Allison Medical, Inc.
Product Code: FBI110437

Growth Factors of pen needles Market

The global pen needles market was valued at USD 2.41 billion in 2025. As per the report timeline, the market is projected to grow to USD 2.56 billion in 2026 and further reach USD 4.58 billion by 2034, registering a CAGR of 7.50% during the 2026-2034 forecast period. North America dominated the global market with a 39.60% share in 2025, supported by high adoption of injectable drug delivery devices and a strong presence of established medical device manufacturers.

Pen needles are disposable medical devices used with injection pens to administer drugs such as insulin, GLP-1 receptor agonists, growth hormone, and other injectable therapies. These needles are replaced after single or limited use, which significantly increases recurring demand. The rising prevalence of chronic diseases such as diabetes, osteoporosis, obesity, and hormone deficiencies is a key contributor to market expansion.

MARKET DRIVERS

The increasing global burden of chronic diseases has been a major driver of pen needle demand. In 2025, diabetes accounted for the largest share of pen needle usage, driven by long-term insulin dependence among patients. The expanding adoption of injectable GLP-1 therapies for diabetes and obesity has further increased reliance on pen-based drug delivery systems.

Market players are actively expanding their product portfolios through acquisitions, partnerships, and new launches. For instance, MTD Medical Technology and Devices S.p.A. strengthened its presence in the pen needle segment by acquiring pen needle and blood glucose monitoring businesses, improving product availability across multiple regions. Additionally, the expansion of over-the-counter (OTC) availability of pen needles in developed markets has supported higher accessibility and volume growth.

MARKET RESTRAINTS

Despite strong demand, the pen needles market faces certain limitations. Risks associated with needlestick injuries, injection-site reactions, and infection transmission remain key concerns for patients and healthcare professionals. Improper injection techniques and repeated injections in the same area can result in complications such as lipohypertrophy and skin infections. Furthermore, the availability of alternative treatment options, including oral medications for diabetes and osteoporosis, continues to restrict market penetration in specific patient groups.

SEGMENTATION ANALYSIS

By Product Type:

Standard pen needles held a dominant position, accounting for 67.97% of the global market share in 2026. Their widespread use is driven by cost-effectiveness and high adoption among diabetes patients. Safety pen needles are expected to grow at a faster pace due to increasing awareness regarding needlestick injury prevention.

By Drug Type:

The insulin segment dominated the market with a 75.39% share in 2026, reflecting the high dependence on insulin for diabetes management. GLP-1 and other injectable drug categories are expected to experience steady growth through 2034.

By Disease Indication:

Diabetes remained the leading disease indication, contributing 83.59% of global demand in 2026. This dominance is supported by rising disease prevalence and continuous innovation in insulin delivery systems by manufacturers.

By Needle Size:

The 4 mm needle segment accounted for 49.61% of the market in 2026, driven by reduced pain perception and lower risk of intramuscular injection. Demand for 6 mm needles is increasing due to their balance between safety and delivery efficiency.

By Distribution Channel:

Retail pharmacies dominated the market in 2025 due to patient preference for easy access and in-store availability. Online pharmacies are projected to grow rapidly through 2034, supported by home delivery convenience and digital healthcare adoption.

REGIONAL INSIGHTS

North America remained the leading region, driven by advanced healthcare infrastructure and strong manufacturer presence. The regional market reached USD 0.96 billion by 2026, supported by companies such as Embecta Corp. and Cardinal Health.

Europe is expected to witness steady growth through 2034, supported by a high prevalence of diabetes and increased preference for self-administered insulin therapies. Asia Pacific is projected to grow at the fastest rate due to expanding patient populations, rising awareness of injectable therapies, and increased pharmaceutical investments in countries such as China, India, and Japan.

KEY INDUSTRY PLAYERS

The competitive landscape includes Novo Nordisk A/S, Terumo Corporation, BD, Owen Mumford, and B. Braun SE. These companies continue to focus on innovation, safety-enhanced designs, and global distribution expansion.

REPORT COVERAGE

The pen needles market report provides detailed insights into market size trends for 2025, 2026, and 2034, along with segmentation analysis, regional outlook, competitive landscape, and the impact of COVID-19. The report also covers key industry developments, including mergers, acquisitions, partnerships, and new product launches influencing market dynamics during the forecast period.

CONCLUSION

The global pen needles market demonstrates consistent expansion across the report timeline, supported by strong demand from chronic disease management and the growing preference for self-administered injectable therapies. With the market valued at USD 2.41 billion in 2025, rising to USD 2.56 billion in 2026, and projected to reach USD 4.58 billion by 2034, growth remains firmly anchored in diabetes care, which accounted for 83.59% of total demand in 2026. The dominance of standard pen needles (67.97% share in 2026) and shorter needle sizes such as 4 mm (49.61% share in 2026) reflects patient preference for cost-effective, low-pain solutions. Regionally, North America's leadership (39.60% share in 2025) highlights the impact of advanced healthcare infrastructure and high adoption of injection pens. Continued innovation, portfolio expansion, and broader accessibility through retail and online pharmacies are expected to sustain market momentum through 2034.

Segmentation By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Drug Type

  • Insulin
  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication

  • Diabetes
  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Standard Pen Needles
    • 5.1.2. Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Needle Size
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Standard Pen Needles
    • 6.1.2. Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Needle Size
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Standard Pen Needles
    • 7.1.2. Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Needle Size
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Standard Pen Needles
    • 8.1.2. Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Needle Size
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. Australia
    • 8.6.4. India
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Standard Pen Needles
    • 9.1.2. Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Needle Size
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Standard Pen Needles
    • 10.1.2. Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Needle Size
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
    • 10.6.2. GCC
    • 10.6.3. Rest of Latin America

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Embecta Corp.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. B. Braun SE
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Owen Mumford
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BD
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Cardinal Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SOL-Millennium
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Terumo Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. MTD Medical Technology and Devices S.p.A.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. UltiMed, Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Allison Medical, Inc.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 3: Global Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 4: Global Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 5: Global Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 6: Global Pen Needles Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: North America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 9: North America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 10: North America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 11: North America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 12: North America Pen Needles Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 15: Europe Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 16: Europe Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 17: Europe Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 18: Europe Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 21: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 22: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 23: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 24: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 27: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 28: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 29: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Latin America Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 33: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 34: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 35: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 36: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Pen Needles Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 4: Global Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 5: Global Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 6: Global Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 7: Global Pen Needles Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 9: North America Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 11: North America Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 12: North America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 13: North America Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 14: North America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 15: North America Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 16: North America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 17: North America Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 18: North America Pen Needles Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America Pen Needles Market Value Share (%), By Country, 2025
  • Figure 20: Europe Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 21: Europe Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 23: Europe Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 24: Europe Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 25: Europe Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 26: Europe Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 27: Europe Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 28: Europe Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 29: Europe Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 30: Europe Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 35: Asia Pacific Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 36: Asia Pacific Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 37: Asia Pacific Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 38: Asia Pacific Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 39: Asia Pacific Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 40: Asia Pacific Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 41: Asia Pacific Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 42: Asia Pacific Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 45: Latin America Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 47: Latin America Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 48: Latin America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 49: Latin America Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 50: Latin America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 51: Latin America Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 52: Latin America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 53: Latin America Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 54: Latin America Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 59: Middle East & Africa Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 60: Middle East & Africa Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 61: Middle East & Africa Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 62: Middle East & Africa Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 63: Middle East & Africa Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 64: Middle East & Africa Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 65: Middle East & Africa Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 66: Middle East & Africa Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Pen Needles Market Share (%), By Company, 2025